Immunization status and re-immunization of childhood acute lymphoblastic leukemia survivors
- 3 September 2020
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (4) , 1132-1135
Abstract
Intensive chemotherapy can cause long-lasting immunosuppression in children who survived cancer. The immunosuppression varies according to the type of cancer, intensity of chemotherapy and age of the patient. A sufficient immune reconstruction when has been completed in childhood cancer survivors, the re-vaccination program can achieve sufficient antibody levels for some of the life-threatening vaccine-preventable infectious diseases. This study evaluates the serological status of pediatric acute lymphoblastic leukemia (ALL) cases before and after the intensive chemotherapy treatment. Antibodies against measles, mumps, rubella, varicella, hepatitis A and B were tested with the enzyme-linked immunosorbent assay (ELISA) method. Antibody titers were measured firstly at the leukemia diagnosis time when the chemotherapy was not started. The second evaluation of antibody titers was studied at 6 months after the cessation of chemotherapy for all patients. Forty-six patients with the mean age of 6.1 ± 4.5 years were participated in this study. Changing to seronegative after treatment was significantly different in measles, rubella, hepatitis A and hepatitis B (p < .05). Seventy-eight (28%) antibody levels in the patients were non-protective for all diseases. Only three (7%) patients had protective antibody levels for all diseases in the sixth month of chemotherapy cessation. There was a negative correlation between patient’s age and losing protective antibody levels for any vaccine-preventable disease (p < .05). Antibody levels against vaccine-preventable diseases have evident that reduced after ALL treatment at childhood. Pediatric ALL survivors must be re-vaccinated for vaccine-preventable diseases after achieving immune reconstruction.Keywords
This publication has 17 references indexed in Scilit:
- Leukemias in ChildrenIndian Journal of Pediatrics, 2015
- Guidelines on Vaccinations in Paediatric Haematology and Oncology PatientsBioMed Research International, 2014
- Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised HostClinical Infectious Diseases, 2014
- Childhood and adolescent cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Screening for Coagulopathy and Identification of Children With Acute Lymphoblastic Leukemia at a Higher Risk of Symptomatic Venous ThrombosisJournal of Pediatric Hematology/Oncology, 2013
- MEASLES, MUMPS, AND RUBELLA ANTIBODY STATUS AND RESPONSE TO IMMUNIZATION IN CHILDREN AFTER THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIAPediatric Hematology and Oncology, 2010
- Survivors of childhood cancer: An Australian audit of vaccination status after treatmentPediatric Blood & Cancer, 2009
- Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic reviewLeukemia, 2006
- Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk groupPediatric Blood & Cancer, 2004
- Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapyCancer, 2004